Hospital Acquired Infections (HAI) Market 2026: COVID-19 Impact Analysis & Top Players - 3M, Advanced Sterilization Products, STERIS Corp, Belimed AG, Pfizer Inc, Abbott Laboratories

The Hospital Acquired Infections (HAI) market is estimated to reach a market value of USD XX million by 2025 with the market growing at a CAGR of XX% in the forecasted period 2019-2026. Hospital-acquired infections (HAI), or nosocomial infections, are acquired in a hospital or other health care facilities.

Get Free PDF Sample Brochure @ https://decisionmarketreports.com/request-sample/1326858

Market Dynamics:
Most common factors causing the growth of the hospital acquired infection market is the growing elderly population globally as the elderly population is more prone to infections due to their low physical immunity. Moreover, the low level of hygiene in hospitals, poor infrastructure management, and poor sterilizing techniques used at healthcare institutions are consequently increasing the number of hospital acquired infection cases.

National 2015 Standardized Infection Ratios (SIRs) Calculated

HAI Type Hospitals Predicted Infection
o Catheter-associated Urinary Tract Infection (CAUTI) 4,165 27,029
o Central Line-associated Bloodstream Infection (CLABSI) 3,935 27,313
o Surgical Site Infection (SSI)- Abdominal Hysterectomy 3,248 2,091
o MRSA Bacteremia LabID Event 4,035 8,898
o Surgical Site Infection (SSI) - Colon Surgery 3,395 9,280

Increasing incidences of different types of hospital acquired infection, advancement in technologies implemented in devices that control infection are some of the growth factors boosting the HAI market. However, lack of awareness towards hospital acquired infections, and increasing use of outpatient treatment are hindering the growth of the market.

Know More about research methodology @ https://decisionmarketreports.com/request-methodolgy/1326858

Market Segment analysis:
o The global hospital acquired infection market is segmented by infection type into Urinary Tract Infections, Ventilator Associated Pneumonia, Bloodstream Infections, Surgical Site Infections, and Others. Among these, the Urinary Tract Infections hold the largest market share in 2017 with increasing patients undergoing urological manipulations, long-stay elderly male patients and patients with debilitating diseases. The urinary tract infections segment is also growing at the highest CAGR during the forecast period.
o Further, based on treatment, the Hospital Acquired Infections (HAI) market is segmented into antibacterial, antiviral, antifungal, and other treatments. Among these, the antibacterial treatment segment accounted for the largest market share in 2017, due to their increased efficiency in hospital acquired infections.
o The below graph shows the estimated number of healthcare-associated infections (HAIs) in U.S. acute care hospitals in 2011. Based on a survey, it was estimated that around 722 thousand HAIs occurred in U.S hospitals in 2011.

Clinical Trial Analysis of Hospital Acquired Infections (HAI):
Total No. of Study: 262

Key Market Segments
o Infection Type
o Urinary Tract Infections
o Ventilator Associated Pneumonia
o Bloodstream Infections
o Surgical Site Infections
o Others

Treatment Type
o Antibacterial Treatment
o Antiviral Treatment
o Antifungal Treatment
o Others

Geography Analysis:
Geographically, the Hospital Acquired Infections (HAI) market is segmented into North America, Europe, Asia-Pacific, South America, and RoW. North America is dominating the global HAI market due to growing development of new therapeutic procedures in bacterial infections.

Competitive Landscape:
o The global Hospital Acquired Infections (HAI) market is a highly consolidated with few companies accounting for majority of the market share. Companies are highly investing in R & D and are collaborating with other companies for developing products.
o Some of the major companies in global Hospital Acquired Infections (HAI)market include 3M, Advanced Sterilization Products, Becton Dickinson and company, STERIS Corp., Getinge AB, Cantel Medical Corp., Belimed AG, Abbott Laboratories, Pfizer Inc., and Bayer AG.
o Some of the recent development contributing to the growth of the global Hospital Acquired Infections market are:
o In March 2017, Pfizer Launches Zavicefta (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria.
o In May 2018, PCT Ltd, formerly Bingham Canyon Corporation, a leading provider of cleaning and disinfecting solutions, introduced its Annihilyzer(R) Infection Control System that is designed to help alleviate the growing problems of Hospital Acquired Infections (HAI's).

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +18666051052
Email: sales@decisionmarketreports.com
Web: http://decisionmarketreports.com/

Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

This release was published on openPR.